コングニーション・セラピューティクス | 10-Q：Q3 2024 四半期報告書

SEC11/13 20:48

Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update

GlobeNewswire11/13 20:30

Press Release: Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update

Dow Jones11/13 20:30

Cognition Therapeutics 3Q Loss/Shr 25c >CGTX

Dow Jones11/13 20:30

Cognition Therapeutics to Present at Zacks SCR Life Sciences Investor Forum

GlobeNewswire11/12 20:30

Cognition Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones11/04 19:33